Patents by Inventor H. David Humes

H. David Humes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8425446
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: April 23, 2013
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington
  • Patent number: 8425447
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: April 23, 2013
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington
  • Patent number: 8425445
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: April 23, 2013
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington
  • Patent number: 8409126
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: April 2, 2013
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington
  • Publication number: 20120322138
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: August 23, 2012
    Publication date: December 20, 2012
    Applicants: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • Publication number: 20120323224
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: August 23, 2012
    Publication date: December 20, 2012
    Applicants: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • Publication number: 20120277720
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: June 25, 2012
    Publication date: November 1, 2012
    Applicants: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • Publication number: 20120258011
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: June 25, 2012
    Publication date: October 11, 2012
    Applicants: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • Patent number: 8251941
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: August 28, 2012
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington
  • Patent number: 8048419
    Abstract: Extracorporeal cell-based therapeutic devices and delivery systems are disclosed which provide a method for therapeutic delivery of biologically active molecules produced by living cells in response to a dynamic physiologic environment. Exemplary designs are disclosed. In a first exemplary embodiment the device includes long hollow fibers in which a layer of cells are grown within the intraluminal volume or within a double hollow-filled chamber. In another exemplary embodiment the device includes a wafer or a series of wafers forms a substrate onto which cells are grown. The wafer(s) are then inserted into a device. The devices are intended to be extracorporeal. Disclosed is a device for delivering a pre-selected molecule, for example, a hormone, into a mammal's systemic circulation. The device may also deliver a member of different cell products. The device comprises an anchoring element that can be anchored to an inner wall of an extracorporeal tube for blood.
    Type: Grant
    Filed: February 1, 2007
    Date of Patent: November 1, 2011
    Assignee: Innovative BioTherapies, Inc.
    Inventor: H. David Humes
  • Publication number: 20110196280
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: April 15, 2011
    Publication date: August 11, 2011
    Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, INNOVATIVE BIOTHERAPIES, INC.
    Inventors: H. David Humes, Deborah Buffington
  • Publication number: 20110190679
    Abstract: Extracorporeal cell-based therapeutic devices and delivery systems are disclosed which provide a method for therapeutic delivery of biologically active molecules produced by living cells in response to a dynamic physiologic environment. One embodiment includes long hollow fibers in which a layer of cells are grown within the intraluminal volume or within a double hollow-filled chamber. Another embodiment includes a wafer or a series of wafers providing a substrate onto which cells are grown. The wafer(s) are inserted into a device. A device may deliver a pre-selected molecule, for example, a hormone, into a mammal's systemic circulation and/or may deliver a member of different cell products. The device is adapted to secure viable cells which produce and secrete the pre-selected molecule into blood or fluid. The invention also provides a minimally invasive method for percutaneously introducing into a preselected blood vessel or body cavity the device of the invention.
    Type: Application
    Filed: February 15, 2011
    Publication date: August 4, 2011
    Applicant: Innovative BioTherapies, Inc.
    Inventors: H. David Humes, Deborah Buffington, Gretchen Hageman
  • Patent number: 7874998
    Abstract: The present invention relates to filtration devices and related methods of use. In particular, the present invention relates to implantable filtration devices used, for example, for filtering impurities from a body fluid of a subject.
    Type: Grant
    Filed: November 6, 2006
    Date of Patent: January 25, 2011
    Assignee: The Regents of the University of Michigan
    Inventors: H. David Humes, David L. Brown
  • Publication number: 20100266563
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: June 30, 2010
    Publication date: October 21, 2010
    Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, INNOVATIVE BIOTHERAPIES, INC.
    Inventors: H. David Humes, Deborah Buffington
  • Publication number: 20100266562
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: June 30, 2010
    Publication date: October 21, 2010
    Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, INNOVATIVE BIOTHERAPIES, INC.
    Inventors: H. David Humes, Deborah Buffington
  • Publication number: 20100268146
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: June 30, 2010
    Publication date: October 21, 2010
    Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, INNOVATIVE BIOTHERAPIES, INC.
    Inventors: H. David Humes, Deborah Buffington
  • Publication number: 20100268147
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: June 30, 2010
    Publication date: October 21, 2010
    Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, INNOVATIVE BIOTHERAPIES, INC.
    Inventors: H. David Humes, Deborah Buffington
  • Patent number: 7540963
    Abstract: The present invention relates to ultrafiltration. In particular, the present invention provides a compact ultrafiltration device and methods for generating an ultrafiltrate, both of which can be used for a variety of applications, including, but not limited to filtering blood, diagnostic applications, and as a bioreactor.
    Type: Grant
    Filed: May 19, 2006
    Date of Patent: June 2, 2009
    Assignees: The Regents of the University of Michigan, The Cleveland Clinic Foundation
    Inventors: William H. Fissell, IV, H. David Humes, Shuvo Roy, Aaron Fleischman
  • Patent number: D629893
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: December 28, 2010
    Assignee: CytoPherx, Inc
    Inventor: H. David Humes
  • Patent number: D630319
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: January 4, 2011
    Assignee: CytoPherx, Inc
    Inventor: H. David Humes